Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Sollis Health offers concierge medical centers that provide on-demand care for families, including same-day visits and virtual care options.
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Genomics plc aiming to lead the genomic transformation of healthcare.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Foresite Capital has invested in 130 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Eikon Therapeutics received $350.7M in a Series D round. Foresite Capital's total known invested capital is $12.6B.
Foresite Capital's average investment size is $127.7M across its portfolio of 130 companies.
Recent Foresite Capital portfolio additions include LifeMine Therapeutics, Engrail Therapeutics, Latigo Biotherapeutics, Twist Bioscience, ImmPACT Bio. These companies were founded in 2020 or later.